SC 13G/AAMENDMENTPYXSCIK 0001782223

Pyxis Oncology, Inc.

Name: SEC EDGAR filing 0001104659-24-114823
Creator: Pyxis Oncology, Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G/A) filed November 6, 2024.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Filing facts

Accession number: 0001104659-24-114823
Filer: Pyxis Oncology, Inc.
Ticker: PYXS
CIK: 0001782223
Form type: SC 13G/A
Form description: 5%+ passive stake
Filed at: November 6, 2024
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 56.1 KB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1782223/000110465924114823/0001104659-24-114823-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Pyxis Oncology, Inc. (0001782223) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001104659-24-114823.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.